Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Cogle

Showing results (21-30 of 137) with videos related to

Pageof 14
Sort By:
Healthcare (Basel, Switzerland)|April 3, 2021
Implementation of Cancer Plans in the United States: A ReviewMichael W Bacchus, Bobbie McKee, Clement K Gwede, et al.
Advances in Virology|February 8, 2012
Oncolytic virotherapy for hematological malignanciesSwarna Bais, Eric Bartee, Masmudur M Rahman, et al.
Journal of Translational Medicine|February 17, 2006
The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cellsJohn M Ninos, Leigh C Jefferies, Christopher R Cogle, et al.
Blood|May 3, 2011
Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registriesChristopher R Cogle, Benjamin M Craig, Dana E Rollison, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 13, 2012
Underreporting of myeloid malignancies by United States cancer registriesBenjamin M Craig, Dana E Rollison, Alan F List, et al.
Leukemia Research|August 20, 2011
Diagnostic testing, treatment, cost of care, and survival among registered and non-registered patients with myelodysplastic syndromesBenjamin M Craig, Dana E Rollison, Alan F List, et al.
Annals of Clinical and Laboratory Science|February 28, 2006
Donor-derived type II pneumocytes are rare in the lungs of allogeneic hematopoietic cell transplant recipientsDani S Zander, Christopher R Cogle, Neil D Theise, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2012
Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virusEric Bartee, Winnie M Chan, Jan S Moreb, et al.
Leukemia Research|July 24, 2020
Patient and physician perceptions about blood transfusions in the myelodysplastic syndromesDavid King, Rodney Schmidt, Matthew Lesser, et al.
Leukemia Research|August 16, 2015
Bone marrow niche in the myelodysplastic syndromesChristopher R Cogle, Najmaldin Saki, Elahe Khodadi, et al.
Pageof 14

Showing results (21-30 of 137) with videos related to

Sort By:
Pageof 14
Healthcare (Basel, Switzerland)|April 3, 2021
Implementation of Cancer Plans in the United States: A ReviewMichael W Bacchus, Bobbie McKee, Clement K Gwede, et al.
Advances in Virology|February 8, 2012
Oncolytic virotherapy for hematological malignanciesSwarna Bais, Eric Bartee, Masmudur M Rahman, et al.
Journal of Translational Medicine|February 17, 2006
The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cellsJohn M Ninos, Leigh C Jefferies, Christopher R Cogle, et al.
Blood|May 3, 2011
Incidence of the myelodysplastic syndromes using a novel claims-based algorithm: high number of uncaptured cases by cancer registriesChristopher R Cogle, Benjamin M Craig, Dana E Rollison, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 13, 2012
Underreporting of myeloid malignancies by United States cancer registriesBenjamin M Craig, Dana E Rollison, Alan F List, et al.
Leukemia Research|August 20, 2011
Diagnostic testing, treatment, cost of care, and survival among registered and non-registered patients with myelodysplastic syndromesBenjamin M Craig, Dana E Rollison, Alan F List, et al.
Annals of Clinical and Laboratory Science|February 28, 2006
Donor-derived type II pneumocytes are rare in the lungs of allogeneic hematopoietic cell transplant recipientsDani S Zander, Christopher R Cogle, Neil D Theise, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2012
Selective purging of human multiple myeloma cells from autologous stem cell transplantation grafts using oncolytic myxoma virusEric Bartee, Winnie M Chan, Jan S Moreb, et al.
Leukemia Research|July 24, 2020
Patient and physician perceptions about blood transfusions in the myelodysplastic syndromesDavid King, Rodney Schmidt, Matthew Lesser, et al.
Leukemia Research|August 16, 2015
Bone marrow niche in the myelodysplastic syndromesChristopher R Cogle, Najmaldin Saki, Elahe Khodadi, et al.
Pageof 14